DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Femara (Letrozole) - Current Clinical Trials

 
 



Femara Related Clinical Trials

RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF [Recruiting]

Letrozole (Femara) Plus Imatinib Mesylate (Gleevec) for Breast Cancer Patients [Active, not recruiting]

Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer [Recruiting]

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients [Recruiting]

Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer [Completed]

Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer [Active, not recruiting]

Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer [Completed]

Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Terminated]

Letrozole in Patients With Ovarian Tumors [Terminated]

Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma [Completed]

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer [Completed]

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer [Active, not recruiting]

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma [Active, not recruiting]

Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic [Completed]

A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma [Recruiting]

Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer [Active, not recruiting]

The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS) [Completed]

Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC [Completed]

Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer. [Recruiting]

Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer [Completed]

Preoperative Combination of Letrozole, Everolimus, and TRC105 in Postmenopausal Hormone-Receptor Positive and Her2 Negative Breast Cancer [Not yet recruiting]

Letrozole as a Treatment of Endometrial Cancer [Completed]

Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles? [Withdrawn]

Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer [Completed]

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer [Active, not recruiting]

Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET [Completed]

Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene [Enrolling by invitation]

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer [Completed]

Pilot of Letrozole for Uterine Myomas [Recruiting]

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. [Completed]

Ovulation Induction in Clomiphene Citrate Resistant PCO Women [Completed]

Letrozole or Combined Clomiphene Citrate Metformin as a First Line Treatment in Women With Polycystic Ovarian Syndrome [Completed]

Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions [Completed]

Use of Letrozole Pretreatment With Misoprostol for First-Trimester Medical Abortion [Recruiting]

Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer [Terminated]

Letrozole Pretreatment With Misoprostol for Second-Trimester Medical Abortion [Recruiting]

The Clinical Trial of Acupuncture Pre-treatment on PCOS [Not yet recruiting]

Antagonist/Letrozole in Poor Responders [Completed]

To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer [Active, not recruiting]

Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer [Completed]

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer [Recruiting]

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy [Completed]

Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer [Active, not recruiting]

Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer [Active, not recruiting]

The Effect of 7 Days of Letrozole Pretreatment Combined With Misoprostol on the Placental and Decidual Tissues [Completed]

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer [Recruiting]

A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix [Recruiting]

GCC 0901 - Study of How Well Letrozole Works in Combination With Lapatinib Followed by an Addition of Everolimus in Postmenopausal Women With Advanced Endocrine Resistant Breast Cancer [Active, not recruiting]

Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women [Recruiting]

Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions [Completed]

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Recruiting]

Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer [Completed]

Extended Letrozole Regimen Versus Clomiphene Citrate for Superovulation in Patients With Unexplained Infertility Undergoing Intrauterine Insemination [Completed]

Study of Breast Cancer Prevention by Letrozole in High Risk Women [Active, not recruiting]

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) [Active, not recruiting]

Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer [Terminated]

Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4) [Active, not recruiting]

Food Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg [Completed]

Fasting Study of Letrozole Tablets 2.5 mg and Femara� Tablets 2.5 mg [Completed]

Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS) [Recruiting]

PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer [Terminated]

A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4] [Recruiting]

Letrozole Treatment in Normal and GnRH Deficient Women [Active, not recruiting]

Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Conditions [Completed]

Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting Conditions [Completed]

Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women [Completed]

Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI) [Completed]

Endocrinology Profile in Patients Undergoing Clomiphene, Letrozole, and Combination Clomiphene and Letrozole Cycles [Not yet recruiting]

RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer [Terminated]

Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer [Active, not recruiting]

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment [Completed]

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer [Recruiting]

Letrozole or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome. [Completed]

Phase Ib Dose-escalation, Phase II Study of LEE011 and Letrozole for Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer [Recruiting]

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer [Completed]

Letrozole Combined With Gonadotropins (Gn) for Ovarian Stimulation Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) in Patients With Polycystic Ovary Syndrome (PCOS) [Enrolling by invitation]

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer [Completed]

Efficacy of Letrozole and CC Alone in an IUI Program in Cases With Surgically Treated Minimal to Mild Endometriosis [Completed]

Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer [Terminated]

BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer [Recruiting]

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer [Completed]

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer [Active, not recruiting]

Letrozole or Combined Metformin Clomiphene Citrate (CC) for Women With CC Resistant Polycystic Ovary Syndrome [Completed]

BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer [Completed]

Dosage Optimization for Letrozole Treatment [Completed]

PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE [Terminated]

Protocol for Women at Increased Risk of Developing Breast Cancer [Completed]

Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer [Completed]

Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation [Active, not recruiting]

Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer. [Terminated]

Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. [Active, not recruiting]

Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer [Completed]

Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients [Completed]

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer [Active, not recruiting]

Letrozole After Tamoxifen in Treating Women With Breast Cancer [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017